Omada Health, Inc. (OMDA) reported $91.31 million in revenue for the quarter ended September 2026, representing a year-over-year increase of 34.2%. EPS of $0.17 for the same period compares to $0.02 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $85.75 million, representing a surprise of +6.48%. The company delivered an EPS surprise of +88.89%, with the consensus EPS estimate being $0.09.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Omada Health, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
-
Total Members: 1,100,000 compared to the 1,121,363 average estimate based on two analysts.
-
Revenue- Services: $85.11 million versus $79.54 million estimated by two analysts on average.
-
Revenue- Hardware: $6.2 million versus $6.21 million estimated by two analysts on average.
View all Key Company Metrics for Omada Health, Inc. here>>>
Shares of Omada Health, Inc. have returned -7% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Omada Health, Inc. (OMDA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
